HER2DX genomic assay in advanced HER2-positive (HER2+) breast cancer treated with T-DM1

被引：0

作者：

Braso-Maristany, F. ^{[1
]}

Griguolo, G. ^{[2
]}

Chic, N. ^{[3
]}

Pare Brunet, L. ^{[3
]}

Galvan, P. ^{[4
]}

Dieci, M. V. ^{[5
]}

Miglietta, F. ^{[6
]}

Giarratano, T. ^{[7
]}

Martinez-Saez, O. ^{[8
]}

Marin, M. ^{[8
]}

Vidal Losada, M. J. ^{[9
]}

Adamo, B. ^{[10
]}

Munoz, M. ^{[11
]}

Vivancos, A. ^{[12
]}

Villagrasa Gonzalez, P. ^{[13
]}

Parker, J. ^{[13
]}

Perou, C. M. ^{[14
]}

Conte, P. F. ^{[15
]}

Prat, A. ^{[16
]}

Guarneri, V. ^{[17
]}

机构：

[1] IDIBAPS Inst Invest Biomed August Pi & Sunyer, Dept Oncol, Barcelona, Spain

[2] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy

[3] Reveal Genom SL, Dept Sci, Barcelona, Spain

[4] IDIBAPS August Pi & Sunyer Biomed Res Inst, Dept Med Oncol, Barcelona, Spain

[5] Univ Padua, DiSCOG, Padua, Italy

[6] IOV Ist Oncol Veneto IRCCS, Dipartimento Oncol, Padua, Italy

[7] IOV Ist Oncologico Veneto IRCCS, Dept Oncol, Padua, Italy

[8] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[9] Hosp Clin Barcelona, Breast Canc, Barcelona, Spain

[10] Hosp Clin Prov Barcelona, Breast Canc Dept, Barcelona, Spain

[11] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[12] Vall Hebron Univ sity Hosp, Genom Dept, Barcelona, Spain

[13] UNC, Dept Oncol, Lineberger Canc Ctr, Chapel Hill, NC USA

[14] UNC, Dept Oncol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[15] IOV Ist Oncol Veneto IRCCS, Surg Oncol & Gastroenterol Dept, Padua, Italy

[16] Hosp Clin Prov Barcelona, Dept Med Oncol, Barcelona, Spain

[17] Univ Padua, Oncol & Gastroenterol Dept, Dept Surg, Padua, Italy

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.276

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

237P

引用

页码：S646 / S646

页数：1